management of the infertile couple in a primary care setting. part i
DESCRIPTION
This is intended for primary care physicians. It is a 2 part presentation that begins with gynecologic cancer screening and ends with the evaluation and management of the infertile coupleTRANSCRIPT
MANAGEMENT OF THE INFERTILE COUPLE IN A
PRIMARY CARE SETTINGPART ONE
MILIE NWOYE MD
SHAPE ARMY MEDICAL CLINIC
FEBRUARY 20TH 2014
OUTLINE
• GENERAL GYNECOLOGY
• Gynecologic cancer screening
• Pre-conception counselling
• Tests for ovarian reserve
• THE INFERTILE COUPLE
• Definition
• Evaluating the infertile couple
• Managing the infertile couple (PART 1)
CERVICAL CANCER SCREENING
• Screening starts at age 21 regardless of sex initiation
• Ages 21-29: Pap test only every 3 years
• Ages 30-65: Pap test every 3 years OR Pap and high risk HPV testing every 5 years
• Women without a cervix: No Pap test required except less than 20 year history of high
grade abnormality OR history of DES in-utero exposure
Population Recommended Screening
Method
Comment
Women younger than 21 years No screening
Women aged 21–29 years Cytology alone every 3 years
Women aged 30–65 years Human papillomavirus and cytology
co-testing (preferred) every 5 years
Cytology alone (acceptable) every 3
years
Screening by HPV testing alone is
not recommended
Women older than 65 years No screening is necessary after
adequate negative prior screening
results
Women with a history of CIN 2, CIN
3 or adenocarcinoma in situ should
continue routine age-based
screening for at least 20 years
Women who underwent total
hysterectomy
No screening is necessary Applies to women without a cervix
and without a history of CIN 2, CIN
3, adenocarcinoma in situ, or cancer
in the past 20 years
Practice bulletin, ACOG, November 2012
BREAST CANCER SCREENING
• Mammography has a false negative rate of 20%*
• Age <40: Self breast awareness
• Age >40: Self breast awareness, annual clinical breast exam and mammogram (except
women with first degree relatives with premenopausal breast cancer OR women with
BRCA mutation)
ACOG guidelines
*National Cancer Institute
Mammography
Clinical Breast
Examination
Breast Self-
Examination
Instruction
Breast Self-
Awareness
American College
of Obstetricians
and Gynecologists
Age 40 years and
older annually
Age 20-39 years
every 1-3 years
Consider for high-
risk patients
Recommended
Age 40 years and
older annually
Practice Bulletin, ACOG, August 2011
ENDOMETRIAL CANCER SCREENING
• Most common gynecologic cancer
• No screening tool.
• Red flags: postmenopausal bleeding
• Diagnosis:
• Endometrial biopsy or D&C
• Transvaginal ultrasound
Risk Factor Relative Risk
Longterm high dose
HRT
10-20
Tamoxifen 3-7
PCOS or estrogen
producing tumor
>5
Obesity 2-5
Nulliparity 3
ACOG practice bulletin, August 2005
OVARIAN CANCER SCREENING
• Lifetime risk of 1/70
• No evidence that screening leads to earlier
detection or improved survival
• Diagnostic tests: CA 125 and transvaginal
ultrasound
ACOG, July 2007
PRE-CONCEPTION SCREENING
• Folic acid 0.4mg (or 4mg with a history of open neural tube defects)
• Risk factor-based genetic screening/ counselling
• Optimize medical conditions (HTN, DM)
• Domestic violence screening
• Avoid alcohol, tobacco, radiation, and illegal drugs
• Weight reduction
• Vaccinations (Rubella, influenza)
ACOG Committee opinion, 9/2005
TESTING FOR OVARIAN RESERVE
•
ASRM, 2005
Speroff, 2005
THE INFERTILE COUPLEDEFINITION
For women ≤ 35: No conception after 1 year of unprotected intercourse
For women >35: No conception after 6 months of unprotected intercourse
Only 43% seek medical care
Age and infertility. Science 1986;233:1389-94
Age (years) Infertility rates (%)
15-24 4
25-34 13
35-44 30
CAUSES OF INFERTILITY- COUPLES
35%
35%
15%
10%
5%
Tubal and pelvic pathlogy
Male factor
Ovulatory dysfunction
Unexplained
Unusual problems
Speroff, 2005
CAUSES OF FEMALE INFERTILITY
40%
40%
10%
10%
Ovulatory dysfunction
Tubal and pelvic disease
Unexplained
Unusual problems
Speroff, 2005
STANDARD FERTILITY WORK-UP
• Assessment of male factor infertility: semen analysis
• Assessment of ovulation: history, BBT, day 21 progesterone
• Assessment of uterus/endometrium and ovaries: transvaginal ultrasound
• Assessment of tubal patency: hysterosalpingogram or laparoscopy
• Assessment of endometriosis: laparoscopy
ASRM Fact sheet 2005
INFERTILITY MANAGEMENT
• Timed intercourse
• Ovulation induction
• Intrauterine insemination (+/- ovulation induction)
• In-vitro fertilization (IVF)
• Intracytoplasmic sperm injection (ICSI)